08:37
creatine
Creatine's known brain benefits operate through multiple distinct cellular mechanisms in an animal model: it improves mitochondria's capacity to convert ADP into usable ATP (coupled respiration) without raising maximal respiration, and it substantially raises levels of PSD-95, a protein that anchors and stabilizes neurotransmitter receptors and scaffolds signaling proteins to support synaptic plasticity.
A prior video covered clinical (human) data on creatine and the brain; this video instead digs into the mechanisms, starting from the assumption that creatine already benefits the brain.
The mechanistic study is an animal study, since this kind of invasive brain-cell research can't be done in humans; the researchers gave animals a creatine-supplemented diet vs. an identical diet without creatine, then ran brain function and cellular measurements.
Mitochondrial function was measured via a Seahorse assay: mitochondria are isolated from brain cells and their oxygen consumption rate (a proxy for mitochondrial activity) is measured while different stimulants and poisons are added to probe specific mitochondrial functions.
Adding ADP (adenosine diphosphate) tests 'coupled respiration' — how well mitochondria's complex protein 5 (ATP synthase) converts ADP into ATP, the cell's main energy currency.
In the creatine condition, coupled respiration/ADP-to-ATP conversion capacity was substantially and measurably elevated compared to control.
Maximal respiration (the highest possible rate of mitochondrial activity) was unchanged by creatine, indicating the effect is specific to ADP-driven energy conversion rather than a blanket boost to mitochondrial capacity.
The exact mechanism behind creatine's effect on ADP-to-ATP conversion is not explained in this video and is promised for a future video on cell compartments and creatine's interaction with energy molecules.
ADP is abundant during high energy demand, such as exercise or 'deep thought'/critical thinking, tying the mitochondrial finding back to brain function.
PSD-95 is introduced as a neuronal protein central to synaptic plasticity — the brain's capacity to change, which underlies improved brain function.
PSD-95 anchors receptors such as AMPA and NMDA to the cell's actin cytoskeleton, stabilizing them on the cell membrane so they can function in cell-to-cell communication via neurotransmitters.
PSD-95 also scaffolds signaling proteins so they can reach and interact with target receptors, increasing the efficiency of cellular signaling.
More efficient, adaptable brain cells translate into better synaptic plasticity and a greater ability to learn and think critically.
In the study, the creatine condition showed an over 50% increase in PSD-95 levels in brain cells.
The actin cytoskeleton protein itself did not change with creatine, which the video interprets as evidence that creatine has a specific effect on certain cellular components rather than a nonspecific, blanket effect.
Overall conclusion: creatine affects multiple mechanisms in the brain, from mitochondrial energy conversion to receptor-stabilization/synaptic plasticity proteins.
The video explicitly states that because this is mechanistic (animal) work alone, no directly applicable conclusions can be drawn from it in isolation — but paired with previously covered clinical data, it supports creatine's effectiveness for improving brain performance.
The Physionic Insiders extended version is flagged as covering more on mitochondrial and inflammatory mechanisms, plus a companion video covering the human clinical data and nuances.
Creatine's mitochondrial benefit is selective, not global: it boosts the efficiency of ADP-to-ATP conversion (coupled respiration) specifically, while leaving the maximal respiration ceiling unchanged — implying an improvement in energy-conversion efficiency rather than raw mitochondrial capacity.
The PSD-95 effect is likewise component-specific rather than a general cellular effect: PSD-95 rose over 50% while the actin cytoskeleton protein it anchors to was unchanged, suggesting creatine targets particular signaling/anchoring machinery rather than uniformly upregulating cell structure.
The video links ADP abundance not just to exercise but explicitly to 'deep thought' and critical thinking as a high-energy-demand brain state, framing creatine's mitochondrial mechanism as most relevant during cognitively demanding activity, not only physical exertion.
The video is explicit about the limits of its own evidence: mechanistic/animal data alone cannot yield applicable conclusions, and its real-world relevance is only established by layering it on top of separately-covered clinical human data — an explicit statement of how the two evidence types combine.
«a while back we covered the clinical data indicating creatine's effects on the brain but instead of repeating what was mentioned there I'd like to dive deeper into how creatina affects our brain»
— 00:00
«as we can see by the light gray line which is the creatine condition there's elevated mitochondrial capacity for likely energy generation through coupled respiration»
— 02:45
«other measurements like maximal respiration which identifies the highest rate of mitochondrial activity are unchanged with creatine»
— 03:05
«we know that creatine somehow increases mitochondrial activity when ADP is abundant which it often is when there's a high energy demand like exercise or even deep thought critical thinking»
— 03:38
«it's because creatine does nothing to psd95 levels no quite the contrary»
— 07:00
«the gray right bar clearly indicates an over 50% increase so creatine substantially increases psd95 levels in the brain cells»
— 07:20
«because this is mechanistic work we can't draw any applicable information on it alone but this paired with previous investigations on clinical data indicates creatine is effective in improving brain performance»
— 07:59
Reception
Strongly positive reception with multiple personal success stories and praise for the presenter, tempered by a small number of concerns about side effects and skepticism.
The video is a focused mechanistic bridge that pairs an animal study's cellular findings with previously covered human clinical data, and it explicitly flags the evidentiary limits of mechanistic-only data rather than overstating what the animal findings alone can support.
08:37